-
Pharmacogenomics and Personalized Medicine
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Pharmacogenomics and Personalized Medicine
(41,728) Views
Editor in Chief Dr Martin H Bluth
1178-7066
An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. In particular, emphasis will be given to:
- Genomic and proteomic profiling
- Genetics and drug metabolism
- Targeted drug identification and discovery
- Optimizing drug selection & dosage based on patient's genetic profile
- Drug related morbidity & mortality intervention
- Advanced disease screening and targeted therapeutic intervention
- Genetic based vaccine development
- Patient satisfaction and preference
- Health economic evaluations
- Practical and organizational issues in the development and implementation of personalized medicine programs
The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, policy papers, expert opinion and commentary, case reports and extended reports
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
